Welcome to our dedicated page for Aterian SEC filings (Ticker: ATER), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking Aterian Inc. (NASDAQ: ATER) means untangling a steady flow of reports that cover everything from brand acquisitions to Amazon inventory swings. Whether you need the latest Aterian insider trading Form 4 transactions or you are comparing contribution margins across Vremi and Healing Solutions in the annual report, Stock Titan’s AI has already done the heavy lifting.
Start your journey with the 10-K annual report; our AI extracts cash-flow pressure points, goodwill adjustments, and segment performance so the Aterian annual report 10-K simplified reads like a two-page brief. Move to the 10-Q quarterly earnings report for real-time margin trends—simply open the filing and see key ratios highlighted. Need breaking news? Each 8-K material event is translated into plain language within minutes, giving you context on product recalls, financing activity, or leadership changes.
Many investors ask, “How do I spot management’s moves before the market reacts?” Our platform answers with Aterian Form 4 insider transactions in real time; instant alerts flag when executives buy, sell, or receive stock awards. The DEF 14A proxy statement then puts those grants in perspective with an accessible analysis of executive compensation.
- AI-powered summaries explain every filing in simple terms.
- Real-time EDGAR updates—never miss a new 10-Q or 8-K.
- One-click access to Aterian executive stock transactions Form 4.
From understanding Aterian SEC documents with AI to modeling inventory turnover, this page delivers the clarity professionals need—no more digging through 300-page PDFs.
Aterian, Inc. reported a significant decline in sales and continued losses in the first half of 2025 as trade policy changes and softer consumer demand weighed on its business. Net revenue for the quarter ended June 30, 2025 was $19.46 million, down 30.5% from $27.98 million a year earlier, and six-month revenue fell to $34.82 million from $48.20 million. The company recorded a quarterly net loss of $4.86 million and a six-month net loss of $8.76 million, with net loss per share of $0.63 for the quarter and $1.16 year-to-date. Gross margin contracted to 54.3% for the quarter as tariffs raised cost of goods sold and the company implemented price increases that reduced unit volumes.
The balance sheet shows $10.50 million of unrestricted cash and total cash and restricted cash of $11.69 million at June 30, 2025, inventory of $18.50 million, and an accumulated deficit of $720.4 million. Aterian is in compliance with its MidCap credit covenants as of June 30, 2025 and expects compliance through at least September 30, 2026, but discloses substantial doubt about near-term liquidity without additional capital. The company recognized restructuring charges of approximately $1.8 million tied to a May 2025 cost reduction plan expected to yield annualized savings of $5–6 million.
Aterian, Inc. furnished a press release reporting its financial results for the three and six months ended June 30, 2025; that press release is attached as Exhibit 99.1 and is incorporated by reference into the Form 8-K. The Form 8-K notes that the information in Item 2.02, including Exhibit 99.1, is being furnished under the Exchange Act and expressly is not deemed to be filed for purposes of Section 18 and is not incorporated by reference into other filings except by specific reference. The filing also lists a Cover Page Interactive Data File as Exhibit 104. The 8-K provides notice that the company has publicly disclosed its quarterly results via the attached press release, but it does not include any financial line-item figures or performance metrics within the filing itself.
FAQ
What is the current stock price of Aterian (ATER)?
What is the market cap of Aterian (ATER)?
